Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Effects of olanzapine on serum protein phosphorylation patterns in patients with schizophrenia.

Jaros JA, Rahmoune H, Wesseling H, Leweke FM, Ozcan S, Guest PC, Bahn S.

Proteomics Clin Appl. 2015 Oct;9(9-10):907-16. doi: 10.1002/prca.201400148. Epub 2015 May 15.

PMID:
25821032
2.

The complement system in schizophrenia.

Mayilyan KR, Weinberger DR, Sim RB.

Drug News Perspect. 2008 May;21(4):200-10. doi: 10.1358/dnp.2008.21.4.1213349. Review.

3.

Altered levels of acute phase proteins in the plasma of patients with schizophrenia.

Yang Y, Wan C, Li H, Zhu H, La Y, Xi Z, Chen Y, Jiang L, Feng G, He L.

Anal Chem. 2006 Jun 1;78(11):3571-6.

PMID:
16737209
4.

Investigation of allotypes of HLA class III (C2, BF and C4) in patients with schizophrenia.

Wang C, Jian BX, Jiang XD, Zhao XZ.

Chin Med J (Engl). 1992 Apr;105(4):316-8.

PMID:
1618015
5.

Complement genetic markers in schizophrenia: C3, BF and C6 polymorphisms.

Fañanás L, Moral P, Panadero MA, Bertranpetit J.

Hum Hered. 1992;42(3):162-7.

PMID:
1511994
6.

Properdin factor B (Bf) types in schizophrenia.

Rudduck C, Franzén G, Hansson A, Rorsman B.

Hum Hered. 1984;34(5):331-3.

PMID:
6566648

Supplemental Content

Loading ...
Support Center